Introduction: Awareness of risk factors for asthma exacerbation can reduce the morbidity and mortality of the disease. The current study aimed to investigate the risk factors associated with current asthma exacerbations in school-age children. Methods: This study enrolled children who were admitted to a tertiary outpatient paediatric allergy and asthma department and were diagnosed with asthma. Patients and their caregivers underwent an interviewer-administered questionnaire, which obtained information regarding the demographic features and parameters to determine environmental exposures along with previous disease history. Laboratory examinations, including complete blood count with differential, total IgE levels, skin prick tests, and pulmonary function tests, were also performed. Results: A total of 431 children (288 male, 66.8%) with a median age (interquartile range) of 8.1 (6.3–11.2) years were included, among whom 265 (61.5%) had aeroallergen sensitization. Asthma was controlled, partially controlled, and uncontrolled in 154 (35.7%), 53 (12.3%), and 143 (33.2%) patients, respectively. A total of 81 patients (18.8%) experienced asthma exacerbation. Multivariate logistic regression analysis revealed that a history of asthma exacerbation within the last year (odds ratio [confidence interval]) (20.73 [9.95–43.20]; p < 0.001), a shorter asthma duration (<2.5 years) (2.58 [1.44–4.61]; p = 0.001), and a lack of regular controller therapy (4.12 [1.54–10.98]; p = 0.005) were associated with current asthma exacerbation. Discussion/Conclusion: Awareness of risk factors for asthma exacerbation may help physicians treat school-age children with asthma by providing prompt and rational interventions in order to prevent asthma exacerbations.

1.
Song HJ, Blake KV, Wilson DL, Winterstein AG, Park H. Medical costs and productivity loss due to mild, moderate, and severe asthma in the United States. J Asthma Allergy. 2020;13:545–55.
2.
Fleming L. Asthma exacerbation prediction: recent insights. Curr Opin Allergy Clin Immunol. 2018;18(2):117–23.
3.
Federico MJ, Denlinger LC, Corren J, Szefler SJ, Fuhlbrigge AL. Exacerbation-prone asthma: a biological phenotype or a social construct. J Allergy Clin Immunol Pract. 2021;9(7):2627–34.
4.
Yavuz ST, Siebert S, Akin O, Arslan M, Civelek E, Bagci S. Perinatal risk factors for asthma in children with allergic rhinitis and grass pollen sensitization. Allergy Asthma Proc. 2018;39(3):1–7.
5.
Deliu M, Yavuz TS, Sperrin M, Belgrave D, Sahiner UM, Sackesen C, et al. Features of asthma which provide meaningful insights for understanding the disease heterogeneity. Clin Exp Allergy. 2018;48(1):39–47.
6.
Global Initiative for Asthma. Global strategy for asthma management and prevention. 2018. Available from: www.ginasthma.org (accessed August 10, 2022).
7.
Neyzi O, Gunoz H, Furman A, Bundak R, Gokcay G, Darendeliler F, et al. Weight, height, head circumference and body mass index references for Turkish children. Çocuk Sağlığı ve Hastalıkları Dergisi. 2008;51:1–14.
8.
Sahiner UM, Civelek E, Yavuz ST, Buyuktiryaki AB, Tuncer A, Sekerel BE. Skin prick testing to aeroallergen extracts: what is the optimal panel in children and adolescents in Turkey? Int Arch Allergy Immunol. 2012;157(4):391–8.
9.
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.
10.
Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–43.
11.
Covar RA, Szefler SJ, Zeiger RS, Sorkness CA, Moss M, Mauger DT, et al. Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. J Allergy Clin Immunol. 2008;122(4):741–7.e4.
12.
Haselkorn T, Zeiger RS, Chipps BE, Mink DR, Szefler SJ, Simons FER, et al. Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2009;124(5):921–7.
13.
Wu AC, Tantisira K, Li L, Schuemann B, Weiss ST, Fuhlbrigge AL, et al. Predictors of symptoms are different from predictors of severe exacerbations from asthma in children. Chest. 2011;140(1):100–7.
14.
Klok T, Kaptein AA, Duiverman EJ, Brand PL. Long-term adherence to inhaled corticosteroids in children with asthma: observational study. Respir Med. 2015;109(9):1114–9.
15.
Rust G, Zhang S, Reynolds J. Inhaled corticosteroid adherence and emergency department utilization among medicaid-enrolled children with asthma. J Asthma. 2013;50(7):769–75.
16.
Vasbinder EC, Belitser SV, Souverein PC, van Dijk L, Vulto AG, van den Bemt PM. Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children. Patient Prefer Adherence. 2016;10:531–8.
17.
Fuhrman C, Dubus JC, Marguet C, Delacourt C, Thumerelle C, de Blic J, et al. Hospitalizations for asthma in children are linked to undertreatment and insufficient asthma education. J Asthma. 2011;48(6):565–71.
18.
Baker JA, Moore HM, Brinton JT, Federico MJ. Comprehensive in-patient education consult for asthma exacerbations. Respir Care. 2022;67(6):682–7.
19.
Mackay D, Haw S, Ayres JG, Fischbacher C, Pell JP. Smoke-free legislation and hospitalizations for childhood asthma. N Engl J Med. 2010;363(12):1139–45.
20.
Forno E, Lescher R, Strunk R, Weiss S, Fuhlbrigge A, Celedon JC, et al. Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol. 2011;127(3):741–9.
21.
Bossios A, Gourgiotis D, Skevaki CL, Saxoni-Papageorgiou P, Lotvall J, Psarras S, et al. Rhinovirus infection and house dust mite exposure synergize in inducing bronchial epithelial cell interleukin-8 release. Clin Exp Allergy. 2008;38(10):1615–26.
22.
Murray CS, Simpson A, Custovic A. Allergens, viruses, and asthma exacerbations. Proc Am Thorac Soc. 2004;1(2):99–104.
23.
Kanchongkittiphon W, Gaffin JM, Phipatanakul W, Wang G, Phipatanakul W. Indoor environmental exposures and exacerbation of asthma: an update to the 2000 review by the Institute of Medicine. Environ Health Perspect. 2015;123(1):6–20.
24.
De Roos AJ, Kenyon CC, Zhao Y, Moore K, Melly S, Hubbard RA, et al. Ambient daily pollen levels in association with asthma exacerbation among children in Philadelphia, Pennsylvania. Environ Int. 2020;145:106138.
25.
Teach SJ, Gergen PJ, Szefler SJ, Mitchell HE, Calatroni A, Wildfire J, et al. Seasonal risk factors for asthma exacerbations among inner-city children. J Allergy Clin Immunol. 2015;135(6):1465–73.e5.
26.
Yavuz ST, Oksel Karakus C, Custovic A, Kalayci O. Four subtypes of childhood allergic rhinitis identified by latent class analysis. Pediatr Allergy Immunol. 2021;32(8):1691–9.
27.
Grunwell JR, Gillespie S, Morris CR, Fitzpatrick AM. Latent class analysis of school-age children at risk for asthma exacerbation. J Allergy Clin Immunol Pract. 2020;8(7):2275–84.e2.
You do not currently have access to this content.